59798 Federal Register / Vol. 71, No. 196 / Wednesday, October 11, 2006 / Notices 

of the actual period for patent extension. 

In its application for patent extension, 

this applicant seeks 1,713 days of patent 

term extension. 

Anyone with knowledge that any of 

the dates as published are incorrect may 

submit to the Division of Dockets 

Management (see ADDRESSES) written or 

electronic comments and ask for a 

redetermination by December 11, 2006. 

Furthermore, any interested person may 

petition FDA for a determination 

regarding whether the applicant for 

extension acted with due diligence 

during the regulatory review period by 

April 9, 2007. To meet its burden, the 

petition must contain sufficient facts to 

merit an FDA investigation. (See H. 

Rept. 857, part 1, 98th Cong., 2d sess., 

pp. 41–42, 1984.) Petitions should be in 

the format specified in 21 CFR 10.30. 

Comments and petitions should be 

submitted to the Division of Dockets 

Management. Three copies of any 

mailed information are to be submitted, 

except that individuals may submit one 

copy. Comments are to be identified 

with the docket number found in 

brackets in the heading of this 

document. 

Comments and petitions may be seen 

in the Division of Dockets Management 

between 9 a.m. and 4 p.m., Monday 

through Friday. 

Dated: September 22, 2006. 

Jane A. Axelrad, 

Associate Director for Policy, Center for Drug 

Evaluation and Research. 

[FR Doc. E6–16816 Filed 10–10–06; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors of the 

NIH Clinical Center. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

Clinical Center, including consideration 

of personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors of the NIH Clinical Center. 

Date: October 16, 2006. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate the 

Rehabilitation Medicine Program. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: David K. Henderson, MD, 

Deputy Director for Clinical Care, Office of 

the Director, Clinical Center, National 

Institutes of Health, Building 10, Room 6–

1480, Bethesda, MD 20892, 301/402–0244. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need to meet timing limitations imposed by 

the intramural research review cycle. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Dated: October 4, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8602 Filed 10–10–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting; Interagency Autism 

Coordinating Committee 

The National Institutes of Health 

(NIH) hereby announces a meeting of 

the Interagency Autism Coordinating 

Committee (IACC) to be held on 

November 17, 2006, on the NIH campus 

in Bethesda, Maryland. 

The Children’s Health Act of 2000 

(Pub.L. 106–310), Title I, Section 104, 

mandated the establishment of an 

Interagency Autism Coordinating 

Committee (IACC) to coordinate autism 

research and other efforts within the 

Department of Health and Human 

Services (DHHS). In April 2001, the 

HHS Secretary delegated the authority 

to establish the IACC to the National 

Institutes of Health (NIH). The National 

Institute of Mental Health (NIMH) at the 

NIH has been designated the lead for 

this activity. 

The IACC meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the contact person listed below in 

advance of the meeting. 

Name of Committee: Interagency 

Autism Coordinating Committee. 

Date: November 17, 2006. 

Time: 9 a.m.–4 p.m. 

Agenda: Discussion of autism 

activities across Federal agencies. 

Place: National Institutes of Health, 

Building 31, Conference Room 10 (6th 

floor), 31 Center Drive, Bethesda, 

Maryland 20892. 

Contact Person: Ann Wagner, Ph.D., 

Division of Pediatric Translational 

Research and Treatment Development, 

National Institute of Mental Health, 

NIH, 6001 Executive Boulevard, Room 

6184, MSC 9617, Bethesda, Maryland 

20892. E-mail: awagner@mail.nih.gov. 

Phone: 301–443–5944. 

Any member of the public interested 

in presenting oral comments to the 

Committee may notify the contact 

person listed on this notice at least 5 

days in advance of the meeting. 

Interested individuals and 

representatives of organizations may 

submit a letter of intent, a brief 

description of the organization 

represented, and a short description of 

the oral presentation. Presentations may 

be limited to 5 minutes; both printed 

and electronic copies are requested for 

the record. In addition, any interested 

person may file written comments with 

the Committee by forwarding his/her 

statement to the contact person listed on 

this notice. The statement should 

include the name, address, telephone 

number, and, when applicable, the 

business or professional affiliation of 

the interested person. 

Information about the meeting and 

online registration forms are also 

available on-line on the NIMH 

homepage at http://www.nimh.nih.gov/ 

autismiacc/index.cfm. 

Dated: September 29, 2006. 

Raynard S. Kington, M.D., Ph.D., 

Deputy Director, National Institutes of Health. 

[FR Doc. E6–16721 Filed 10–10–06; 8:45 am] 

BILLING CODE 4167–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 522b(c)(6), Title 5 U.S.C., 


pwalker on PRODPC60 with NOTICES
Federal Register / Vol. 71, No. 196 / Wednesday, October 11, 2006 / Notices 59799 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SBIR Topic 

211 and Topic 212 (Phase II). 

Date: November 7, 2006. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20852. 

(Telephone Conference Call). 

Contact Person: Kirt Vener, PhD. Branch 

Chief, Special Review and Logistics Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 6116 Executive 

Boulevard, Room 8061, Rockville, MD 20852. 

(301) 496–7174. venerk@mail.nih.gov. 

Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 1, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8585 Filed 10–10–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group, Clinical Trials 

Review Committee. 

Date: October 30–31, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Hotel Baltimore, 300 

Light Street, Baltimore, MD 21202. 

Contact Person: Patricia A. Haggerty, PhD, 

Section Chief, Clinical Studies and Traning 

Scientific Review Group, Review Branch, 

Division of Extramural Research Activities, 

National Heart, Lung, and Blood Institute, 

NIH, 6701 Rockledge Drive, Room 7194, MSC 

7924, Bethesda, MD 20892, 301/435–0288, 

haggertp@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseasse Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 4, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8601 Filed 10–10–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, HIV 

Prevention. 

Date: October 26, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Chevy Chase, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: David I. Sommers, PhD., 

Scientific Review Administrator, Division of 

Extramural Activities, National Institutes of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9609, 

Bethesda, MD 20892–9606. 301–435–7861. 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

Building Translational Research in 

Integrative Behavioral Science. 

Date: October 26, 2006. 

Time: 10 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Peter J. Sheridan, PhD. 

Scientific Review Administrator, Division of 

Extramural Activities, National Institutes of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892, 301–433–1513. 

psherida@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 1, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8584 Filed 10–10–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, NIAMS. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIAMS. 

Date: November 6–7, 2006. 

Time: November 6, 2006, 6:30 p.m. to 9:30 

p.m. 


pwalker on PRODPC60 with NOTICES